Advocacy News
Obesity Care Continuum Final Comments to Kathleen Sebelius on Health and Human Services Bulliten
Letter to The Food and Drug Administration (FDA)
Comments to the Interagency Working Group on Food Marketed to Children FTC Project No. P094513
OBESITY GROUPS SEE EVIDENCE FDA DECISIONS WILL DISCOURAGE OBESITY RESEARCH
Medicare Coverage Determination Comments
Agenda for FDA 032211 Meeting With FDA
Obesity Experts Meet With FDA on Weight-Loss Drugs
OBESITY GROUPS ENGAGE WITH THE FOOD AND DRUG ADMINISTRATION (FDA) ON OBESITY TREATMENT
The Obesity Society Opposes Georgia's Children's Health Alliance Campaign to Stop Childhood Obesity
Wellness Letter and Wellness Summary: Proposed changes to 71 FR 75014: Nondiscrimination Based on a Health Factor and Wellness Programs
HHS Hold Wellness Forum As Stakeholders Seek Assurance Provisions Won't Cause Underwriting
Obesity Experts Meet With FDA on Weight Loss Drugs
FDA_Letter_011411_TOS_AACE_ASMBS_OAC
Highlights of HR 5209, The Healthy CHOICES Act
TOS Leaders Hit Capitol Hill for Rolling Advocacy Program
TOS Urges FDA to be Fair when Judging New Evidence-Based Treatment Approaches for Obesity
